ロード中...
The Therapeutic Potential of LRRK2 and α-Synuclein in Parkinson's Disease
Current treatments for Parkinson's disease fail to modify disease progression, and the underlying pathogenic mechanisms remain elusive. The identification of specific targets responsible for disease will aid in the development of relevant model systems and the discovery of neuroprotective and n...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Mary Ann Liebert, Inc.
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2787962/ https://ncbi.nlm.nih.gov/pubmed/19271991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/ars.2009.2430 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|